Skip to main content
. Author manuscript; available in PMC: 2011 May 16.
Published in final edited form as: Cancer Biol Ther. 2010 Jun 18;9(12):1017–1024. doi: 10.4161/cbt.9.12.11804

Table 3. Comparison of methylation levels between subtypes of invasive breast carcinoma.

Basal-like vs. luminal Basal-like vs. HER2 Luminal vs. HER2

Gene Global effect1 p value2 Global effect1 p value2 Global effect1 p value2

TWIST 0.412 0.0006 0.422 0.009 -0.042 >0.999

RASSF1A 0.522 <0.0001 0.347 0.048 -0.279 0.090

HIN-1 0.355 0.006 0.467 0.003 0.020 >0.999

CYCLIN D2 0.192 0.336 0.227 0.396 0.004 >0.999

APC1 0.134 0.831 0.457 0.003 0.251 0.153

CDH1 -0.234 0.168 0.350 0.048 0.548 <0.0001

BRCA1 -0.284 0.012 -0.184 0.402 0.142 0.480

RAR-β -0.121 0.975 0.251 0.351 0.276 0.114

ESR1 -0.093 >0.999 -0.029 >0.999 0.076 >0.999

9-gene panel3 0.098 0.165 0.257 <0.0001 0.111 0.210

3-gene panel4 0.430 <0.0001 0.412 0.0002 -0.100 0.861

4-gene panel5 -0.126 0.198 0.218 0.042 0.304 <0.0001
1

An nonparametric estimate measuring the degree of dissimilarity between the two groups.

2

p values obtained using nonparametric rank-sum-type global statistical test and adjusted by Bonferroni correction.

3

9-gene panel includes TWIST, RASSF1A, HIN-1, CYCLIN D2, APC1, CDH1, BRCA1, RAR-β and ESR1.

4

3-gene panel includes TWIST, RASSF1A, HIN-1.

5

4-gene panel includes APC1, RAR-β, CDH1, BRCA1.